Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Brussels-based MAASH secures €12.15 million to scale up mycoprotein production with equity investment from new investors including Ambra Capital and Bpifrance.
PRIVATEAug 25, 2026•about 4 hours ago
Amount Raised
€12.2 Million
Round Type
Venture - Series Unknown
BelgiumBiotechnologyFood and BeverageAgriculture and FarmingFood Processing
Investors
TereosNordzuckerAmorçage IndustrielBpifranceInvest ProAmbra Capital
Description
MAASH, a Brussels-based fermentation company specializing in mycoproteins, has secured a €12.15 million funding package. This includes a €5.85 million equity raise from five new investors and additional public financing support. The funding will enhance their technical and commercial scale-up of mycoprotein production. The company aims to become a leading B2B ingredient supplier for the food industry.
Company Information
Company
MAASH
Location
Belgium
About
MAASH is a Brussels-based fermentation company specializing in the development and production of mycoproteins for the food industry. Founded in 2021, it focuses on creating sustainable ingredients that enhance food products while reducing meat content. The company precisely controls fermentation parameters to ensure optimal yield and product quality. MAASH aims to position itself as a B2B ingredient supplier with its fermentation-derived mycoprotein, LoCylia.
Don't miss MAASH's next move
Get an email the moment MAASH raises, hires an exec, or expands, usually minutes after it happens.
BelgiumBiotechnologyFood and BeverageAgriculture and FarmingFood Processing